Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 1 of 1 for “"UCL Cancer Institute"”.

  1. Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P)

    CA4P leads to rapid vascular shutdown of tumour core, with minimal effects at the well perfused periphery. CA4P showed minimal anti-tumour activity in single agent phase I studies. This thesis examined the feasibility of CA4P combination therapy, examining the hypothesis that two agents may be …

    ucl Repository record for Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P) (opens in a new tab)